BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs

Rheumatology (Oxford). 2017 Jun 1;56(6):865-868. doi: 10.1093/rheumatology/kew479.
No abstract available

Keywords: DMARDs; co-morbidity; drug toxicity; methotrexate; rheumatic disease; safe prescribing; shared care; treatment monitoring.

Publication types

  • Practice Guideline

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Drug Monitoring
  • Drug Prescriptions
  • Humans
  • Rheumatic Diseases / drug therapy*


  • Antirheumatic Agents